Tuesday, December 9th, 2025: Day OneTuesday, 9 December 2025 - ET (Eastern Time, GMT-05:00)

Pharmaceutical manufacturers face the most complex commercialization environment in history. As new regulations, pricing controls, and payer archetypes emerge, companies must rethink how to balance pricing, access, and channel strategies across diverging markets.

• Regulatory Pressure and Market Impact: Navigating MFN, WAC reductions, MFP implementation, 340B rebates, and the Physician Fee Schedule—each reshaping manufacturer margins and channel behaviors.
• The Three Payer Economies:
  • Commercial: high-WAC, high-rebate models losing sustainability
  • Government: statutory rebates extending below cost of goods
  • Cash/Self-Pay: the fastest-growing but least understood market segment
• Lifecycle Alignment: Understanding which product types and lifecycle stages best align with each payer economy
• The Self-Pay Inflection Point: Is it a political anomaly or a lasting market reality for branded pharmaceuticals?
• Strategic Prioritization: Frameworks for deciding where to invest, partner, and pull back
• Channel Reinvention: Balancing legacy distribution and access models with new direct, digital, and white-labeled pathways

As market mergers, joint ventures and more transform the life sciences marketplace, hear from key industry experts on what is changing and what is being forecasted as areas of interest moving forward.

• Gain shared insight and perspectives from seasoned executives in banking and private equity

• Understand market dynamics across different channels

• Focus on areas of investment for private equity and strategic acquirers

• Explore a current market update and M&A outlook

• Understand the fundamental shifts causing industry disruption and market volatility, including how recent executive actions are transforming trade relationships, pricing structures and market access

• Analyze recent and pending legislation with far-reaching implications, including state legislation like AK HB 1531 and AK HB 1530

• Examine the evolving tariff landscape, its impact on global supply chains and strategies for mitigating increased costs

• Explore market-responsive strategies across traditional, limited and direct-to-patient models to address diverse portfolio requirements and changing patient needs

• Discover innovative approaches to align global brand strategies with tactical channel decisions while proactively adapting to regulatory shifts and evolving product dynamics

• Learn how digital-first pharmacy solutions can accelerate patient access, enhance medication adherence and position brands for success in tomorrow's healthcare ecosystem

• Hear directly from leadership representing independent pharmacies, big box retailers, grocery store chains and emerging pharmacy models as they share their unique challenges and opportunities in the changing ecosystem

• Explore how digital-first companies are reshaping consumer expectations and delivery models

• Understand how pharmacy executives are adapting their strategies and organizational structures to address new market pressures, technological advances and changing patient needs

• Explore how to maximize the potential of existing commercial structures and teams to secure assets with commercial potential

• Understand how to position your company to navigate future market volatility and events, ensuring long-term growth and stability

• Discover the benefits of forming strategic partnerships, joint ventures, and alliances to drive growth and share risks in the pharmaceutical market  

• Gain critical insights into the current state of DTP/DTC markets and discover strategic positioning approaches

• Learn operational strategies for successful implementation, including ideal products, innovative payment structures, effective risk mitigation frameworks and meaningful success metrics

• Examine expansion opportunities across healthcare segments through the changing role of traditional wholesalers

This commemorative roundtable marks the conference's 20th anniversary by examining the dramatic evolution of pharmaceutical channels and marketplace dynamics. Industry leaders reflect on pivotal shifts that reshaped the landscape and predict what the future of the channel will be.